Contact us on (02) 8445 2300
For all customer service and order enquiries

Woodslane Online Catalogues

9781615372218 Add to Cart Academic Inspection Copy

The APA Publishing Textbook of Substance Use Disorder Treatment 6/e

Description
Table of
Contents
Google
Preview
A robust revision, including many entirely new chapters addressing policy, the latest treatment approaches, and special topics, the Sixth Edition of The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment offers a comprehensive and compelling review of this ever-evolving field. New sections address important topics that have gained prominence or become the focus of increased research attention since the Fifth Edition was released. For example, substance use and other psychiatric disorders often co-occur, and the resulting dual disorder is frequently associated with greater symptom severity and worse long-term prognosis than either disorder alone. Accordingly, the section on psychiatric comorbidity covers the epidemiology, assessment, and treatment of substance use disorders (SUDs) that co-occur with psychotic, mood, anxiety, eating, attention-deficit/hyperactivity, or trauma-related disorders. The section devoted to special populations has been revamped, and the topics have been thoroughly updated, some now covered by new contributors and others completely new to this edition. SUDs among women (including perinatal issues), adolescents, patients with chronic pain, sexual and gender minority populations, and older adults are addressed in detailed chapters, as are behavioral addictive disorders and cross-cultural aspects of substance-related and addictive disorders. Finally, the editors have included a section devoted to critically important topics in public health, including the U.S. opioid epidemic, cannabis policy and use, HIV/AIDS and hepatitis C, nicotine and public health, and the prevention of SUDs. New or noteworthy coverage includes the following: A chapter devoted to the legal and practical aspects of addiction in the occupational sphere, designed for clinicians who treat people with SUDs and/or develop workplace testing programs, employee assistance programs, and occupational drug/alcohol policies for these workers. A chapter that surveys the growing literature supporting the use of mindfulness, exercise, and other "mind and body" practices (e.g., yoga, acupuncture, tai chi) as complements or alternatives to standard SUD treatment models. A chapter devoted to hallucinogens, which clarifies their actions, psychoactive effects, historical uses, potential therapeutic benefits, and neural mechanisms, and both identifies their risks and seeks to dispel some of the misconceptions that have continued to surround them. A suite of chapters devoted to cannabis, encompassing a review of its neurobiology and history, a survey of effective treatment approaches and harm-reduction strategies for cannabis use disorder, and a consideration of evolving public policy around cannabis use. A trio of chapters devoted to nicotine and tobacco, encompassing a review of neurobiology, a survey of clinical assessment tools, a summary of the research base for effective treatments for tobacco use disorder, and a consideration of public health policy and interventions regarding tobacco use. Evidence-based, down to earth, and meticulously edited, the new Sixth Edition of The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment is an essential resource for clinicians who treat SUDs in a variety of settings -- from examining rooms to emergency departments, and from hospitals to recovery facilities.
ContributorsPart I: The Basis of Substance-Related and Addictive DisordersChapter 1. Neurocircuitry of AddictionChapter 2. Genetics and Epigenetics of AddictionChapter 3. Epidemiology of AddictionChapter 4. Substance Use Disorder Diagnoses in DSM-5Part II: Assessment and TreatmentChapter 5. AssessmentChapter 6. Screening and Brief InterventionChapter 7. Treating Addiction Like a Chronic Illness: A Practical Clinical ModelPart III: Specific Drugs of Abuse: Neurobiology and PharmacotherapyChapter 8. Neurobiology of AlcoholChapter 9. Treatment of Alcohol-Related DisordersChapter 10. Neurobiology of StimulantsChapter 11. Treatment of Stimulant-Related DisordersChapter 12. Neurobiology of OpioidsChapter 13. Methadone and Buprenorphine Maintenance Treatment of Opioid-Related DisordersChapter 14. Opioid Antagonist Treatment of Opioid-Related DisordersChapter 15. Neurobiology and Treatment of Hallucinogen Use DisorderChapter 16. Neurobiology of MarijuanaChapter 17. Treatment of Cannabis-Related DisordersChapter 18. Neurobiology of Nicotine and TobaccoChapter 19. Treatment of Tobacco-Related DisordersChapter 20. Neurobiology and Treatment of Sedative-, Hypnotic-, and Anxiolytic-Related DisordersChapter 21. Neurobiology and Treatment of Anabolic-Androgenic Steroid--Related DisordersPart IV: Nonpharmacotherapeutic Treatment ModalitiesChapter 22. Psychodynamic PsychotherapyChapter 23. Cognitive-Behavioral TherapyChapter 24. Contingency ManagementChapter 25. Motivational EnhancementChapter 26. Alcoholics Anonymous and Twelve-Step FacilitationChapter 27. Family TherapyChapter 28. Network TherapyChapter 29. Digitally Delivered TherapiesChapter 30. Mindfulness, Exercise, and Other Alternative ApproachesPart V: Public Health IssuesChapter 31. The U.S. Opioid CrisisChapter 32. Cannabis Policy and UseChapter 33. HIV/AIDS and Hepatitis CChapter 34. Public Health and NicotineChapter 35. Prevention of Substance Use DisordersPart VI: Special PopulationsChapter 36. Substance-Related Disorders in WomenChapter 37. Substance-Related Disorders in AdolescentsChapter 38. Substance-Related Disorders in Patients With Chronic PainChapter 39. Substance Use and Related Disorders in Sexual and Gender Minority PopulationsChapter 40. Cross-Cultural Aspects of Substance-Related and Addictive DisordersChapter 41. Substance-Related Disorders in Older AdultsChapter 42. Behavioral Addictive DisordersPart VII: Psychiatric Comorbidity in Substance-Related DisordersChapter 43. Epidemiology of Co-Occurring Psychiatric and Substance Use DisordersChapter 44. Mood DisordersChapter 45. Anxiety DisordersChapter 46. Eating DisordersChapter 47. Attention-Deficit/Hyperactivity DisorderChapter 48. Trauma- and Stressor-Related DisordersChapter 49. Schizophrenia Spectrum and Other Psychotic DisordersPart VIII: Special TopicsChapter 50. Testing for Substances of AbuseChapter 51. Forensic Addiction PsychiatryChapter 52. Medical Education on AddictionChapter 53. Addiction in the WorkplaceIndex
Google Preview content